Evidence map›Paper›PMID 32855620›Full record

ArticleCancer cell international2020

Epigenetic silencing of long non-coding RNA

Zhenhai Li, Shaji Kumar, Dong-Yan Jin, George A Calin, Wee-Joo Chng, Kam-Leung Siu, Ming-Wai Poon, Chor Sang Chim

Open access · goldAbstract read
In one paragraph

Article in Cancer cell international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Potential Clinical Role of LncRNA miR503HG in Multiple Myeloma and its Effect on the Proliferation and Adhesion of Myeloma Cells.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2024
    Article
  3. Long non‑coding RNAs in multiple myeloma (Review).International journal of oncology · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Zhenhai LiGuangdong Key Laboratory of Genome Instability and Human Disease Prevention, Department of Biochemistry and Molecular Biology, Shenzhen University School of Medicine, Shenzhen, China.
Shaji KumarDivision of Hematology, Mayo Clinic, Rochester, MN USA.
Dong-Yan JinSchool of Biomedical Sciences, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
George A CalinDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX USA.
Wee-Joo ChngDepartment of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
Kam-Leung SiuSchool of Biomedical Sciences, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Ming-Wai PoonDepartment of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road, Pokfulam, Hong Kong, China.
Chor Sang ChimDepartment of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road, Pokfulam, Hong Kong, China.ORCID 0000-0003-2427-915X
Queen Mary Hospital · CNMayo Clinic · USNational University Cancer Institute, Singapore · SGShenzhen University · CNThe University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong non-coding RNA (lncRNA)

methodsMethylation-specific PCR and quantitative bisulfite pyrosequencing were performed to detect the methylation of

results

conclusionsThis is the first report of tumor-specific methylation-mediated silencing of

Indexed as

BM742401DNA methylationMultiple myelomaOverall survival

Identifiers

PMID32855620
PMCPMC7446116
OpenAlexW3081046864

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.